Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. - Wikidata - awgldk - TriplyDB

Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.

Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.

http://www.wikidata.org/entity/Q46529658

about

Pathogenesis of Helicobacter pylori infection Concurrent gastric and pulmonary mucosa-associated lymphoid tissue lymphomas with pre-existing intrinsic chronic inflammation: a case report and a review of the literature Clinical Rationale for Confirmation Testing After Treatment of Helicobacter pylori Infection: Implications of Rising Antibiotic Resistance.American College of Gastroenterology guideline on the management of Helicobacter pylori infection.Signet Ring Cell Gastric Cancer Occurring after Radiation Therapy for Helicobacter pylori-Uninfected Mucosa-Associated Lymphoid Tissue Lymphoma.Recognition of changes in microvascular and microstructural patterns upon magnifying endoscopy predicted the presence of extranodal gastric MALToma Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation.Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status.Helicobacter pylori: present status and future prospects in Japan.Therapy of gastric mucosa-associated lymphoid tissue lymphoma.Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.Therapy of gastric mucosa associated lymphoid tissue lymphoma.Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management.Strategies for gastric cancer in the modern era.Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma H. pylori Management in ASEAN: the Bangkok Consensus Report.Radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma: long-term outcomes over 10 years.Molecular Aspects of H. pylori-Related MALT Lymphoma Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.The Human Gastric Pathogen Helicobacter pylori and Its Association with Gastric Cancer and Ulcer Disease Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study

P2860

Q24679810-D17C3C64-9C20-421E-AFD4-B1CD4D9481DF Q27026867-E16AE603-1939-40A8-9986-0024842B83BB Q34448307-3D63811E-613E-4C70-801F-58E1B63ECF11 Q34645482-317A9410-3DAC-413D-ABD3-85C175C2AEC2 Q35071361-8E5B7CC9-42B6-43BA-958A-BE7A29BEDAB3 Q35954973-7CA03355-FBC0-4D07-A8A6-4C101D613B30 Q36023405-14716C13-288E-4861-896D-606B40A49309 Q36584820-862D3E0C-CE62-4A0E-9555-BCAD6A8CB2FA Q36681114-669B486F-C1C4-4F68-92A4-E07463D66956 Q36745437-F62A958E-730C-408D-AAC1-49ADAD3EE3A3 Q36847291-A92C48BD-C687-4DF0-AE7D-4C9E26EDA23C Q36870112-151DA314-795F-49B2-BE7A-06C782CD0CD7 Q36894785-9B8B6856-0245-4060-89D7-DDB017FDF01F Q37224102-8DF59E70-B5DE-493A-89F6-E0277B2615FC Q37821266-46BC18BF-81B0-4CAA-9B9C-E4D599AD7496 Q37932613-91E61F81-0FB2-400F-BE83-64AFBEA5F109 Q38100784-123A98D8-57FA-4E8F-9E2E-C380063816AD Q40100019-0D53A581-7E1F-4B17-AA5B-3ED8AFDA7E44 Q41511282-1EF96DE6-6557-4E16-A25E-0495BB6952C3 Q42591363-1CF1D1BA-7832-424A-AE61-D56A3EC4DF84 Q43954123-9A8D7A9F-E5A6-4028-A50C-777534A773AF Q56984398-24BF542A-FD61-4ED2-A4F1-28D03EDB7A32 Q57224018-709E1065-34BF-4EE2-8F0C-77FE1034CCAB Q57903193-2811D19D-779A-4ACE-821B-A584D591B05A

P2860

Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.

http://www.wikidata.org/entity/Q46529658

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Long-term clinical outcome of ...... ence to second-line treatment.

@en

Long-term clinical outcome of ...... ence to second-line treatment.

@nl

type

label

Long-term clinical outcome of ...... ence to second-line treatment.

@en

Long-term clinical outcome of ...... ence to second-line treatment.

@nl

prefLabel

Long-term clinical outcome of ...... ence to second-line treatment.

@en

Long-term clinical outcome of ...... ence to second-line treatment.

@nl

P1433

Q46529658-F16A9FE0-CC49-4221-887B-4D60658B6996

P1476

Q46529658-994815B4-172E-4B70-B76E-94F0EE0A1455

P2093

Q46529658-12D5822B-FFD1-469C-AFBE-EC4304FC2A62

Q46529658-42A21D00-11BA-4700-8CC8-94C871007920

Q46529658-6C0AAEEC-2166-45A1-8387-91450DF4293E

Q46529658-76375293-A426-40E4-877A-152B44D77C6D

Q46529658-97FE04E1-3018-47F6-911F-21509462A198

Q46529658-BF39378D-EC5C-4538-966C-0BBE9BB06166

Q46529658-D158CBAD-CD77-4932-B0E8-33B9AB8DCD3B

Q46529658-EB616A41-052A-4FA5-BE2F-CA37495E1E87

P2860

Q46529658-A7D008FD-5598-4FE2-8495-18008CBBB4D8

Q46529658-AF435C49-A84F-4644-BAE8-F60D516E958E

P304

Q46529658-902E7CBF-4182-4B9F-9C68-C91AC674C0EE

P31

Q46529658-0CC34328-2488-4C7D-A6BA-23D9BF74B97B

P356

Q46529658-C5F38F7F-0C87-4DDC-A162-99F953542ACC

P407

Q46529658-23E7C1EF-9197-4364-BC8A-4B2850CA1636

P433

Q46529658-1AD1843E-619E-443B-BEF9-BAD570B5CDA8

P478

Q46529658-CCF60805-10A6-446A-9740-791583F2D32B

P577

Q46529658-16CA3D2F-B8F1-46D0-8E16-054325E45737

P5875

Q46529658-0AB0A18D-D5B4-47CA-BC9D-CF023E734B24

P698

Q46529658-7A8DA8ED-290C-4A7B-83FE-153BC6753754

P921

Q46529658-91146B19-EF92-4086-A678-79B3003DEACD

P356

P1433

P1476

Long-term clinical outcome of ...... ence to second-line treatment.

@en

P2093

Hiroshi Matsumoto

http://www.w3.org/2001/XMLSchema#string

Hiroshi Suekane

http://www.w3.org/2001/XMLSchema#string

Mitsuo Iida

http://www.w3.org/2001/XMLSchema#string

Motohiro Esaki

http://www.w3.org/2001/XMLSchema#string

Shigeo Nakamura

http://www.w3.org/2001/XMLSchema#string

Shotaro Nakamura

http://www.w3.org/2001/XMLSchema#string

Takashi Yao

http://www.w3.org/2001/XMLSchema#string

Takayuki Matsumoto

http://www.w3.org/2001/XMLSchema#string

P2860

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.

Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.

P304

532-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.21152

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7804262

http://www.w3.org/2001/XMLSchema#string

P698

15937928

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori